Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Pudendal Nerve Block With Articaine and Triamcinolone in Patients With Pudendal Neuropathy
NCT07828574Active, not recruiting
- Sponsor
- Irkutsk State Medical University
- Start
- Jan 2025
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
Randomised, triple-blind trial of articaine and triamcinolone acetonide in pudendal neuralgia (PN) (2 arms), sponsored by Irkutsk State Medical University. Primary endpoint: Proportion of Participants With ≥50% Reduction in Pain Intensity at 4 weeks. Started Jan 2025; status: active, not recruiting.
02
Drugs
articainetriamcinolone acetonide
03
Conditions
pudendal neuralgia (PN)
Beyond the preview
Go deeper on NCT07828574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07828574.